Stage
Series B | AliveTotal Raised
$15.17MLast Raised
$11.8M | 14 yrs agoMissing: Portaero's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Portaero's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Portaero Patents
Portaero has filed 38 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
11/9/2012 | 10/8/2013 | Respiratory therapy, Lung disorders, Medical equipment, Respiratory diseases, Respiratory physiology | Grant |
Application Date | 11/9/2012 |
|---|---|
Grant Date | 10/8/2013 |
Title | |
Related Topics | Respiratory therapy, Lung disorders, Medical equipment, Respiratory diseases, Respiratory physiology |
Status | Grant |
Latest Portaero News
Jun 11, 2013
VentureWire , June 10, 2013, (c) 2013 Dow Jones & Company, Inc. After raising about $20 million in equity and debt from venture capitalists since its founding in 2007, medical-device company Portaero Inc. is putting its assets up for sale, according to a statement from Gerbsman Partners, a restructuring firm that handles such transactions. The firm's principal, Steven Gerbsman, said the firm does not comment beyond a simple written synopsis once the firm has been retained to find a buyer for a company.... Document DJFVW00020130610e96as4781 To continue reading this story login at the top right or try the product Document DJFVW00020130610e96as4781 Exclusive news and deep analysis of what’s really happening with venture capital-backed companies, their investors,and their management teams.
Portaero Frequently Asked Questions (FAQ)
Where is Portaero's headquarters?
Portaero's headquarters is located at 21631 Stevens Creek Boulevard, Cupertino.
What is Portaero's latest funding round?
Portaero's latest funding round is Series B.
How much did Portaero raise?
Portaero raised a total of $15.17M.
Who are the investors of Portaero?
Investors of Portaero include Versant Ventures, Aberdare Ventures and Novartis Venture Funds.
Who are Portaero's competitors?
Competitors of Portaero include SetPoint Medical, ALung Technologies, iTind, Relievant Medsystems, PulmonX and 13 more.
Compare Portaero to Competitors
Apneon is an early stage medical device company developing devices for the treatment of sleep apnea.
Perfuzia Medical is developing the next generation of medical devices for the treatment of chronic wounds.
Insense Ltd has developed and patented a technology platform centred on the feature of in-situ wound oxygenation. Its first products, Oxyzyme and Iodozyme, target chronic wounds and will be launched into the professional healthcare market.
Stealth mode medical device company developing devices for drug delivery. Monterey Devices submitted a patent on device for buffering anesthetics.
Medical devices for the treatment of severe gastrointestinal disorders
SetPoint Medical develops a bioelectronic medicine platform using a small implanted device that activates the body's natural inflammatory reflex and produces a systemic anti-inflammatory effect. It aims to treat patients with chronic autoimmune diseases and provides a treatment alternative for rheumatoid arthritis, inflammatory bowel disease, and other chronic autoimmune conditions. The company was founded in 2006 and is based in Santa Clarita, California.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.